Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of venous thromboembolism in hemorrhagic stroke patients
2016-003627-29Phase 3Terminated
- Sponsor
- Azienda Ospedaliera di Perugia
- Start
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of enoxaparin in intracerebral hemorrhage (ICH) and brain hemorrhage (ICH) (2 arms), sponsored by Azienda Ospedaliera di Perugia. Primary endpoint: Composite venous thromboembolism endpoint. Started Mar 2018; status: terminated.
02
Drugs
enoxaparin
03
Conditions
intracerebral hemorrhage (ICH)brain hemorrhage (ICH)
Beyond the preview
Go deeper on 2016-003627-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003627-29.